{"id":{"repo_id":"baylor","oai_identifier":"oai:baylor-ir.tdl.org:2104/9799"},"canonical_url":"https://search.dev.ndltd.org/etd/baylor/oai:baylor-ir.tdl.org:2104/9799","repository":{"repo_id":"baylor","name":"Baylor University","base_url":"https://baylor-ir.tdl.org/server/oai/request"},"display":{"title":"Plant-produced, trans-encapsidated, replicative viral nanoparticles as a vaccine platform.","abstract":"Replicative virus-based vaccines provide potential solutions to avoid the natural deficits of traditional single-protein subunit vaccines. Unlike subunit vaccines, the infectious nature of viral particles can stimulate the innate immune response, which allows enhanced and elongated stimulation of antibody and T cell adaptive immunity. When these replicative vaccines are engineered to express antigen genes naturally in the patient's cells, cell mediated immunity is stimulated via the class I antigen presentation pathway, followed by a robust CD8+ T cell activation and interferon production. In this study, I aim to develop a safe, effective and cost-efficient transencapsidated replicative vaccine platform by encapsidating within strongly immunogenic tobacco mosaic virus (TMV) nanoparticles the self-replicative RNA of Flock House virus (FHV), an insect virus that also replicates in human and plant cells. By inserting the unique packaging signal of TMV into FHV RNA, the capsid of TMV assembles around the heterologous RNA, when TMV coat protein and FHV RNA are expressed in the same cell. First, the replication of different viral delivery vectors in both mammalian cells and plant cells was investigated and their cellular co-infection was demonstrated. The resulting successfully packaged chimeric nanoparticle improved antibody production over the standards after vaccination in mice. Next I detailed the specifics and techniques required to produce and purify these nanoparticle vaccines in planta via agroinoculation. To further explore the possibility of increasing the yield of plant-produced nanoparticle vaccines, an optimized spray-on inoculation method was developed using a low-toxicity surfactant to aid agro-inoculation. Unexpectedly, this also decreased contaminating plant pathogenesis-related proteins. A continuing study is also discussed on trans-locating FHV replication to endoplasmic reticulum, which suggests potential to further increase plant yield of nanoparticle vaccines as well.","abstract_html":"Replicative virus-based vaccines provide potential solutions to avoid the natural deficits of traditional single-protein subunit vaccines. Unlike subunit vaccines, the infectious nature of viral particles can stimulate the innate immune response, which allows enhanced and elongated stimulation of antibody and T cell adaptive immunity. When these replicative vaccines are engineered to express antigen genes naturally in the patient's cells, cell mediated immunity is stimulated via the class I antigen presentation pathway, followed by a robust CD8+ T cell activation and interferon production. In this study, I aim to develop a safe, effective and cost-efficient transencapsidated replicative vaccine platform by encapsidating within strongly immunogenic tobacco mosaic virus (TMV) nanoparticles the self-replicative RNA of Flock House virus (FHV), an insect virus that also replicates in human and plant cells. By inserting the unique packaging signal of TMV into FHV RNA, the capsid of TMV assembles around the heterologous RNA, when TMV coat protein and FHV RNA are expressed in the same cell. First, the replication of different viral delivery vectors in both mammalian cells and plant cells was investigated and their cellular co-infection was demonstrated. The resulting successfully packaged chimeric nanoparticle improved antibody production over the standards after vaccination in mice. Next I detailed the specifics and techniques required to produce and purify these nanoparticle vaccines in planta via agroinoculation. To further explore the possibility of increasing the yield of plant-produced nanoparticle vaccines, an optimized spray-on inoculation method was developed using a low-toxicity surfactant to aid agro-inoculation. Unexpectedly, this also decreased contaminating plant pathogenesis-related proteins. A continuing study is also discussed on trans-locating FHV replication to endoplasmic reticulum, which suggests potential to further increase plant yield of nanoparticle vaccines as well.","abstract_has_math":false,"creators":["Zhou, Yiyang, 1988-"],"institution":"Baylor University.","degree_name":"Ph.D.","degree_level":"Doctoral","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Kearney, Christopher Michel, 1958-"],"committee_chairs":[],"committee_members":[],"year":2016,"date_issued":"2016-08","date_published":"2016-08","updated_at":"2026-07-24T01:07:56Z","subjects":["Virus.","Vaccine."],"languages":["en"],"rights":["Baylor University works are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact libraryquestions@baylor.edu for inquiries about permission."],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2104/9799","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Kearney, Christopher Michel, 1958-"]},{"key":"dc:creator","label":"Author","values":["Zhou, Yiyang, 1988-"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2016-09-01T13:03:57Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2016-09-01T13:03:57Z"]},{"key":"dc:date.issued","label":"Date","values":["2016-08"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Baylor University."]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Virus.","Vaccine."]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Baylor University works are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact libraryquestions@baylor.edu for inquiries about permission."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2104/9799"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Replicative virus-based vaccines provide potential solutions to avoid the natural deficits of traditional single-protein subunit vaccines. Unlike subunit vaccines, the infectious nature of viral particles can stimulate the innate immune response, which allows enhanced and elongated stimulation of antibody and T cell adaptive immunity. When these replicative vaccines are engineered to express antigen genes naturally in the patient's cells, cell mediated immunity is stimulated via the class I antigen presentation pathway, followed by a robust CD8+ T cell activation and interferon production. In this study, I aim to develop a safe, effective and cost-efficient transencapsidated replicative vaccine platform by encapsidating within strongly immunogenic tobacco mosaic virus (TMV) nanoparticles the self-replicative RNA of Flock House virus (FHV), an insect virus that also replicates in human and plant cells. By inserting the unique packaging signal of TMV into FHV RNA, the capsid of TMV assembles around the heterologous RNA, when TMV coat protein and FHV RNA are expressed in the same cell. First, the replication of different viral delivery vectors in both mammalian cells and plant cells was investigated and their cellular co-infection was demonstrated. The resulting successfully packaged chimeric nanoparticle improved antibody production over the standards after vaccination in mice. Next I detailed the specifics and techniques required to produce and purify these nanoparticle vaccines in planta via agroinoculation. To further explore the possibility of increasing the yield of plant-produced nanoparticle vaccines, an optimized spray-on inoculation method was developed using a low-toxicity surfactant to aid agro-inoculation. Unexpectedly, this also decreased contaminating plant pathogenesis-related proteins. A continuing study is also discussed on trans-locating FHV replication to endoplasmic reticulum, which suggests potential to further increase plant yield of nanoparticle vaccines as well."]},{"key":"dc:format.mimetype","label":"Dc Format Mimetype","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Plant-produced, trans-encapsidated, replicative viral nanoparticles as a vaccine platform."]}]}],"canonical_facts":{"dc:contributor.advisor":["Kearney, Christopher Michel, 1958-"],"dc:creator":["Zhou, Yiyang, 1988-"],"dc:date.accessioned":["2016-09-01T13:03:57Z"],"dc:date.available":["2016-09-01T13:03:57Z"],"dc:date.issued":["2016-08"],"dc:description.abstract":["Replicative virus-based vaccines provide potential solutions to avoid the natural deficits of traditional single-protein subunit vaccines. Unlike subunit vaccines, the infectious nature of viral particles can stimulate the innate immune response, which allows enhanced and elongated stimulation of antibody and T cell adaptive immunity. When these replicative vaccines are engineered to express antigen genes naturally in the patient's cells, cell mediated immunity is stimulated via the class I antigen presentation pathway, followed by a robust CD8+ T cell activation and interferon production. In this study, I aim to develop a safe, effective and cost-efficient transencapsidated replicative vaccine platform by encapsidating within strongly immunogenic tobacco mosaic virus (TMV) nanoparticles the self-replicative RNA of Flock House virus (FHV), an insect virus that also replicates in human and plant cells. By inserting the unique packaging signal of TMV into FHV RNA, the capsid of TMV assembles around the heterologous RNA, when TMV coat protein and FHV RNA are expressed in the same cell. First, the replication of different viral delivery vectors in both mammalian cells and plant cells was investigated and their cellular co-infection was demonstrated. The resulting successfully packaged chimeric nanoparticle improved antibody production over the standards after vaccination in mice. Next I detailed the specifics and techniques required to produce and purify these nanoparticle vaccines in planta via agroinoculation. To further explore the possibility of increasing the yield of plant-produced nanoparticle vaccines, an optimized spray-on inoculation method was developed using a low-toxicity surfactant to aid agro-inoculation. Unexpectedly, this also decreased contaminating plant pathogenesis-related proteins. A continuing study is also discussed on trans-locating FHV replication to endoplasmic reticulum, which suggests potential to further increase plant yield of nanoparticle vaccines as well."],"dc:format.mimetype":["application/pdf"],"dc:identifier.uri":["https://hdl.handle.net/2104/9799"],"dc:language.iso":["en"],"dc:rights":["Baylor University works are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact libraryquestions@baylor.edu for inquiries about permission."],"dc:subject":["Virus.","Vaccine."],"dc:title":["Plant-produced, trans-encapsidated, replicative viral nanoparticles as a vaccine platform."],"dc:type":["Thesis"],"thesis:degree_level":["Doctoral"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["Baylor University."]},"updated_at":"2026-07-24T01:07:56Z"}